Company intelligence / Profile preview
Tonghua Dongbao
Tonghua, Jilin, Chinathdb.com ↗
- Ownership
- Private
- Employees
- ~3196
- Development stage
- Other
01
Overview
Tonghua Dongbao is a leading Chinese pharmaceutical company specializing in diabetes care. It was the first to launch recombinant human insulin in China ("Gansulin") and now markets a range of insulin analogs and diabetes therapies domestically and internationally. Its biosimilar insulins are approved for use in several countries; it continues to expand its global regulatory footprint with ongoing clinical trials for new formulations such as ultra-fast acting insulins. The company recently discontinued development of BioChaperone Combo but continues late-stage work on BioChaperone Lispro with Adocia. It ranks among China's top pharma companies by revenue.
- Therapeutic areas
- Metabolic DisordersEndocrinologyImmunologyGastroenterologyCardiovascularNeurology
- Modalities
- BiosimilarSmall moleculeHormoneRecombinant polypeptideSynthetic peptideRecombinant protein
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Adocia SAS – partnership/licensing for BioChaperone Lispro ultra-fast acting insulin program remains active; previous partnership on BioChaperone Combo discontinued July 2024.
Beyond the preview
Go deeper on Tonghua Dongbao.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tonghua Dongbao.